Concepedia
Statistics
Publications
3
Citations
119
H-Index
Active since
2022
Affiliations
University of Chicago(Current)
Hospital Universitario Insular de Gran Canaria
Merck & Co., Inc., Rahway, NJ, USA (United States)
Westmead Hospital
Ospedale San Luigi Gonzaga
M.C. Garassino is an author at University of Chicago specializing in medicine, pembrolizumab therapy, and oncology.
Publications per year
2022–2023
LBA56 Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC)
J.D. Spicer, Shugeng Gao, Moïshe Liberman et al. · Annals of Oncology · 2023 · 75 citations · Full text
Medicine, Oncology, Perioperative Medicine +13
973MO KEYNOTE-189 5-year update: First-line pembrolizumab (pembro) + pemetrexed (pem) and platinum vs placebo (pbo) + pem and platinum for metastatic nonsquamous NSCLC
M.C. Garassino, S.M. Gadgeel, G. Speranza et al. · Annals of Oncology · 2022 · 31 citations
Medicine, Pharmacology, Pharmacotherapy +10
OA15.06 Pooled Analysis of Outcomes with Second-Course Pembrolizumab Across 5 Phase 3 Studies of Non-Small-Cell Lung Cancer
Delvys Rodríguez‐Abreu, Y.-L. Wu, M. Boyer et al. · Journal of Thoracic Oncology · 2022 · 13 citations
Medicine, Oncology, Pharmacotherapy +9
1–3 of 3